Arkolith/Insider Trading/AKBA/Form 4

Grund Nicholas

Chief Commercial OfficerAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$118K
Net Open-Market Flow
-$118K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)54K$1.39$74K593K
Feb 2, 2026Sell(S)31K$1.39$43K562K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001661887-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML